
ValveCure
Rob Kirk, JD, OD
Corporate Financial Advisor and Board Level structuralist for Financial Analysis,
Reporting, Accounting, Management Consulting, Healthcare Consulting and Corporate
Law. Financial executive and business consultant as Principal of a successful
investment banking firm and legal advisory group, managing companies from startup
to $40M in annual revenues in the biotech/life science, ophthalmic, and energy sectors.

Christopher D. Kline, PhD
Founder and President of Metis Strategies, a management consultant and executive
advisor to founders, CEOs, and leadership teams navigating growth, transition, and exit.
Over a 30-year career, he has advised organizations across North America, Europe, and
China on aligning strategy, leadership, and execution to drive margin, scalability, and
enterprise value. He has also served in interim CEO and C-suite roles and supported
operational due diligence, EBITDA improvement, and post-acquisition integration.

Edward Hlozek, CEO and Chairman
Edward Hlozek, CEO and Chairman
CEO of Mind & Associates, Inc., and ValveCure founder. Director of interventional and surgical/medical minimally invasive companies in cardiac, neurologic, orthopedic, urologic, gynecologic, pulmonary and ENT markets. Financial and clinical
oversight for Class I, II & III devices and techniques in all surgical and minimally invasive
sub-specialties which include RF therapy devices. Designer and patent holder for the
current transcatheter platform technologies of ValveCure.
